{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:21:28Z","timestamp":1792693288525,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.adengl.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T13:22:05Z","timestamp":1620739325000},"page":"601-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cutaneous and Mucocutaneous Leishmaniasis"],"prefix":"10.1016","volume":"112","author":[{"given":"I.","family":"Abad\u00edas-Granado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Diago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Cerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Palma-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gilaberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adengl.2021.05.011_bib0005","author":"World Health Organization"},{"key":"10.1016\/j.adengl.2021.05.011_bib0010","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2009.03.004","article-title":"Tropical dermatology: Tropical diseases caused by protozoa","volume":"60","author":"Lupi","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.adengl.2021.05.011_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New World and Old World Leishmania Infections: A Practical Review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.adengl.2021.05.011_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2014.08.051","article-title":"Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives","volume":"73","author":"Handler","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0030","first-page":"555","article-title":"Situaci\u00f3n epidemiol\u00f3gica y de los factores de riesgo de transmisi\u00f3n de Leishmania infantum en Espa\u00f1a","volume":"86","author":"Su\u00e1rez Rodr\u00edguez","year":"2012","journal-title":"Rev Esp Salud Publica."},{"key":"10.1016\/j.adengl.2021.05.011_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2807\/1560-7917.ES2015.20.7.21037","article-title":"Spatial distribution and cluster analysis of a leishmaniasis outbreak in the south-western Madrid region, Spain, September 2009 to April 2013","volume":"20","author":"Gomez-Barroso","year":"2015","journal-title":"Euro Surveill."},{"key":"10.1016\/j.adengl.2021.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3201\/eid2506.181027","article-title":"Leishmaniasis in Norway Rats in Sewers, Barcelona, Spain","volume":"25","author":"Gal\u00e1n-Puchades","year":"2019","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.adengl.2021.05.011_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007708","article-title":"Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression","volume":"13","author":"Bosch-Nicolau","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0055","doi-asserted-by":"crossref","first-page":"taz055","DOI":"10.1093\/jtm\/taz055","article-title":"GeoSentinel Surveillance Network. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis","volume":"26","author":"Boggild","year":"2019","journal-title":"J Travel Med."},{"key":"10.1016\/j.adengl.2021.05.011_bib0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.3535070","article-title":"Leishmaniasis and malaria: new tools for epidemiologic analysis","volume":"234","author":"Wirth","year":"1986","journal-title":"Science."},{"key":"10.1016\/j.adengl.2021.05.011_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0035-9203(02)90044-1","article-title":"Mechanisms of pathogenesis: differences amongst Leishmania species","volume":"96","author":"Colmenares","year":"2002","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0080","first-page":"331","article-title":"Identificaci\u00f3n de la Leishmania tr\u00f3pica mexicana como agente etiol\u00f3gico de la Ulcera de los Chicleros","volume":"135","author":"Quijano-Pitman","year":"1999","journal-title":"Gac Med Mex."},{"key":"10.1016\/j.adengl.2021.05.011_bib0085","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1590\/s1678-9946201759033","article-title":"Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil","volume":"59","author":"Carvalho","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"10.1016\/j.adengl.2021.05.011_bib0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.actatropica.2017.05.022","article-title":"Atypical presentations of cutaneous leishmaniasis: A systematic review","volume":"172","author":"Meireles","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.adengl.2021.05.011_bib0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijid.2018.07.008","article-title":"Leishmaniasis recidivans by Leishmania tropica in Central Rift Valley Region in Kenya","volume":"74","author":"Gitari","year":"2018","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0100","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jdv.13838","article-title":"Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity","volume":"30","author":"Mortazavi","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0049475519852207","article-title":"Diffuse cutaneous leishmaniasis with oral involvement in a patient of Northern Mexico","volume":"49","author":"Mariz","year":"2019","journal-title":"Trop Doct."},{"key":"10.1016\/j.adengl.2021.05.011_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(93)90398-A","article-title":"Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study","volume":"87","author":"David","year":"1993","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0115","first-page":"3","article-title":"Ear, nose and throat manifestations of mucocutaneous Leishmaniasis: a literature review","volume":"85","author":"Marra","year":"2014","journal-title":"Acta Biomed."},{"key":"10.1016\/j.adengl.2021.05.011_bib0120","first-page":"41","article-title":"Clinical profile of Kala-azar in adults: as seen in Mymensingh Medical College Hospital, Mymensingh, Bangladesh","volume":"12","author":"Sarker","year":"2003","journal-title":"Mymensingh Med J."},{"key":"10.1016\/j.adengl.2021.05.011_bib0125","first-page":"86","article-title":"Elevated cortisol level due to visceral leishmaniasis and skin hyper-pigmentation are causally related","volume":"2","author":"ELkhair","year":"2014","journal-title":"Int J Sci Commer Humanit."},{"key":"10.1016\/j.adengl.2021.05.011_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.15429","article-title":"Hyperpigmentation as a guiding sign for the diagnosis of visceral leishmaniasis in a patient with human immunodeficiency virus (HIV)","author":"Abad\u00edas-Granado","year":"2021","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0135","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1128\/JCM.44.3.1178-1180.2006","article-title":"Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient","volume":"44","author":"Stark","year":"2006","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jcp.56.11.840","article-title":"Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods","volume":"56","author":"Salotra","year":"2003","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fcimb.2019.00228","article-title":"Biomarkers in Post-kala-azar Dermal Leishmaniasis","volume":"9","author":"Zijlstra","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.adengl.2021.05.011_bib0155","first-page":"63","article-title":"Leishmaniasis d\u00e9rmica postkala-azar [Postkala-azar dermal leishmaniasis]","volume":"46","author":"de Juan Mart\u00edn","year":"1997","journal-title":"An Esp Pediatr."},{"key":"10.1016\/j.adengl.2021.05.011_bib0160","doi-asserted-by":"crossref","first-page":"e3258","DOI":"10.1371\/journal.pntd.0003258","article-title":"PKDL and other dermal lesions in HIV co-infected patients with leishmaniasis: review of clinical presentation in relation to immune responses","volume":"8","author":"Zijlstra","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.adengl.2021.05.011_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002635","article-title":"Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection","volume":"8","author":"Mock","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.adengl.2021.05.011_bib0175","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the Mediterranean region","volume":"8","author":"Monge-Maillo","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"issue":"Suppl 1","key":"10.1016\/j.adengl.2021.05.011_bib0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0185","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4269\/ajtmh.2011.11-0310","article-title":"Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008)","volume":"85","author":"Gil-Prieto","year":"2011","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0190","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1365-3156.2010.02612.x","article-title":"Challenges in HIV and visceral leishmania co-infection: future research directions","volume":"15","author":"Ejara","year":"2010","journal-title":"Trop Med Int Health."},{"key":"10.1016\/j.adengl.2021.05.011_bib0195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)90109-X","article-title":"Leishmania major and HIV co-infection in Burkina Faso","volume":"97","author":"Guiguemde","year":"2003","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0200","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4269\/ajtmh.2006.75.858","article-title":"Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up","volume":"75","author":"Mary","year":"2006","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0205","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3389\/fimmu.2018.01772","article-title":"Anti-Tumor Necrosis Factor \u03b1 Therapeutics Differentially Affect Leishmania infection of human macrophages","volume":"9","author":"Arens","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.idc.2018.10.004","article-title":"Cutaneous leishmaniasis: updates in diagnosis and management","volume":"33","author":"Aronson","year":"2019","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.adengl.2021.05.011_bib0215","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2014.09.014","article-title":"Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management","volume":"73","author":"Handler","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3855\/jidc.4310","article-title":"Diagnosis of leishmaniasis","volume":"8","author":"Elmahallawy","year":"2014","journal-title":"J Infect Dev Ctries."},{"key":"10.1016\/j.adengl.2021.05.011_bib0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12639-013-0316-3","article-title":"An improved microculture method for diagnosis of cutaneous leishmaniasis","volume":"38","author":"Pagheh","year":"2014","journal-title":"J Parasit Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2010.09.006","article-title":"Diagnosis of visceral leishmaniasis","volume":"105","author":"Srivastava","year":"2011","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0235","first-page":"295","article-title":"Challenges in the diagnosis of post kala-azar dermal leishmaniasis","volume":"123","author":"Salotra","year":"2006","journal-title":"Indian J Med Res."},{"key":"10.1016\/j.adengl.2021.05.011_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/150746","article-title":"Systematic review into diagnostics for post-kala-azar dermal leishmaniasis (PKDL)","volume":"2013","author":"Adams","year":"2013","journal-title":"J Trop Med."},{"key":"10.1016\/j.adengl.2021.05.011_bib0245","author":"U. S. Centers for Disease Control and Prevention"},{"key":"10.1016\/j.adengl.2021.05.011_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0255","doi-asserted-by":"crossref","first-page":"e3255","DOI":"10.1371\/journal.pntd.0003255","article-title":"Caseating Granulomas in Cutaneous Leishmaniasis","volume":"8","author":"Aoun","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0260","first-page":"1","article-title":"Histopathology of cutaneous leishmaniasis","volume":"4","author":"Mehregan","year":"1997","journal-title":"Gulf J Dermatol Venereol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0265","first-page":"294","article-title":"Histopathological spectrum in cutaneous leishmaniasis: a study in Oman","volume":"67","author":"Venkataram","year":"2001","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0270","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2133.2008.08986.x","article-title":"Dermoscopy of cutaneous leishmaniasis","volume":"160","author":"Llambrich","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ijd.12686","article-title":"Clinical and dermoscopic evaluation of cutaneous leishmaniasis","volume":"54","author":"Ayhan","year":"2015","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-4632.2012.05850.x","article-title":"Reevaluating leishmanin skin test as a marker for immunity against cutaneous leishmaniasis","volume":"52","author":"Momeni Boroujeni","year":"2013","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0285","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pntd.0001665","article-title":"The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis","volume":"6","author":"Cota","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0036-46651996000300003","article-title":"Cross-reactivity of antibodies in human infections by the kinetoplastid protozoa Trypanosoma cruzi, Leishmania chagasi and Leishmania (vanni) braziliensis","volume":"38","author":"Vexenat","year":"1996","journal-title":"Rev Inst Med S\u00e3o Paulo."},{"key":"10.1016\/j.adengl.2021.05.011_bib0295","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1017\/S0031182014001607","article-title":"Detection of high levels of anti-alpha-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting","volume":"141","author":"Al-Salem","year":"2014","journal-title":"Parasitology."},{"key":"10.1016\/j.adengl.2021.05.011_bib0300","article-title":"Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease","volume":"6","author":"Boelaert","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.adengl.2021.05.011_bib0305","first-page":"202","article-title":"Performance of latex agglutination test (KAtex) in diagnosis of visceral leishmaniasis in Iran","volume":"6","author":"Ghatei","year":"2009","journal-title":"Iran J Immunol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13071-016-1667-2","article-title":"Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis","volume":"9","author":"Ghosh","year":"2016","journal-title":"Parasit Vectors."},{"key":"10.1016\/j.adengl.2021.05.011_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187024","article-title":"Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani","volume":"12","author":"De Silva","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.adengl.2021.05.011_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149697","article-title":"The cure rate after placebo or no therapy in American cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"11","author":"Cota","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.adengl.2021.05.011_bib0325","article-title":"Interventions for Old World cutaneous leishmaniasis","volume":"4","author":"Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.adengl.2021.05.011_bib0330","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ijd.12685","article-title":"Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis","volume":"54","author":"Ranawaka","year":"2015","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0335","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-4362.1996.tb03669.x","article-title":"Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate","volume":"35","author":"Tallab","year":"1996","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0340","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2010.09865.x","article-title":"Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India","volume":"163","author":"Bumb","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.adengl.2021.05.011_bib0350","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0355","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0360","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14787210.2020.1731305","article-title":"Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis","volume":"18","author":"Fernandes","year":"2020","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.adengl.2021.05.011_bib0365","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007253","article-title":"Topical paromomycin for New World cutaneous leishmaniasis","volume":"13","author":"Sosa","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0375","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.adengl.2021.05.011_bib0380","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12879-016-1663-3","article-title":"Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials","volume":"16","author":"L\u00f3pez-Carvajal","year":"2016","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0385","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1371\/journal.pntd.0000628","article-title":"A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection","volume":"4","author":"Aronson","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0390","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/S0031182018000124","article-title":"The successful use of radiofrequency-induced heat therapy for cutaneous leishmaniasis: a review","volume":"145","author":"David","year":"2018","journal-title":"Parasitology."},{"issue":"5","key":"10.1016\/j.adengl.2021.05.011_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122569","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials","volume":"10","author":"Cardona-Arias","year":"2015","journal-title":"PloS One."},{"key":"10.1016\/j.adengl.2021.05.011_bib0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdv.16044","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications \u2013 field cancerization, photorejuvenation and inflammatory\/infective dermatoses","volume":"34","author":"Morton","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"10","key":"10.1016\/j.adengl.2021.05.011_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186117","article-title":"Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis","volume":"12","author":"Galvao","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.adengl.2021.05.011_bib0410","doi-asserted-by":"crossref","first-page":"ofw008","DOI":"10.1093\/ofid\/ofw008","article-title":"Miltefosine for mucosal and complicated cutaneous Old World leishmaniasis: a case series and review of the literature","volume":"3","author":"Mosimann","year":"2016","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0415","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0292-2018","article-title":"A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis","volume":"52","author":"Sampaio","year":"2019","journal-title":"Rev Soc Bras Med Trop."},{"key":"10.1016\/j.adengl.2021.05.011_bib0420","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019011","article-title":"Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"41","author":"Iranpour","year":"2019","journal-title":"Epidemiol Health."},{"key":"10.1016\/j.adengl.2021.05.011_bib0425","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-4632.2009.04072.x","article-title":"Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis","volume":"48","author":"Firdous","year":"2009","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0430","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","article-title":"Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs."},{"key":"10.1016\/j.adengl.2021.05.011_bib0435","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0440","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4269\/ajtmh.16-0349","article-title":"Mucosal leishmaniasis: a retrospective study of 327 cases from an endemic area of Leishmania (Viannia) braziliensis","volume":"97","author":"Cincur\u00e1","year":"2017","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0445","first-page":"11","article-title":"Liposomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis","volume":"10","author":"Shirzadi","year":"2019","journal-title":"Res Rep Trop Med."},{"key":"10.1016\/j.adengl.2021.05.011_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006094","article-title":"Liposomal amphotericin B in travelers with cutaneous and mucocutaneous leishmaniasis: not a panacea","volume":"11","author":"Guery","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0455","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Liposomal amphotericin B for treatment of cutaneous leishmaniasis","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006653","article-title":"A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia","volume":"12","author":"L\u00f3pez","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0465","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2006.06.044","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis","volume":"56","author":"Solomon","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0470","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis","volume":"86","author":"Neves","year":"2011","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tmaid.2018.02.010","article-title":"Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure","volume":"24","author":"Christen","year":"2018","journal-title":"Travel Med Infect Dis."},{"key":"10.1016\/j.adengl.2021.05.011_bib0480","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4269\/ajtmh.15-0640","article-title":"Intralesional pentamidine: A novel therapy for single lesions of Bolivian cutaneous leishmaniasis","volume":"94","author":"Soto","year":"2016","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.adengl.2021.05.011_bib0485","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.adengl.2021.05.011_bib0490","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S0031182017000385","article-title":"Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review","volume":"144","author":"Nassif","year":"2017","journal-title":"Parasitology."},{"key":"10.1016\/j.adengl.2021.05.011_bib0495","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-3083.2010.03781.x","article-title":"Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate","volume":"25","author":"Shamsi Meymandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0500","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.adengl.2021.05.011_bib0505","doi-asserted-by":"crossref","first-page":"403","DOI":"10.29271\/jcpsp.2019.05.403","article-title":"Comparing the Efficacy of Oral Chloroquine versus Oral Tetracycline in the Treatment of Cutaneous Leishmaniasis","volume":"29","author":"Malik","year":"2019","journal-title":"J Coll Physicians Surg Pak."},{"issue":"suppl 2","key":"10.1016\/j.adengl.2021.05.011_bib0510","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219021001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219021001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:04:19Z","timestamp":1761624259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1578219021001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1578219021001712"],"URL":"https:\/\/doi.org\/10.1016\/j.adengl.2021.05.011","relation":{},"ISSN":["1578-2190"],"issn-type":[{"value":"1578-2190","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous and Mucocutaneous Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adengl.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEDV.","name":"copyright","label":"Copyright"}]}}